共 46 条
- [31] Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (11): : 727 - 736
- [32] Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (07): : 989 - 1003
- [33] Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology Clinical and Translational Oncology, 2020, 22 : 989 - 1003
- [34] Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients Clinical and Translational Oncology, 2009, 11
- [35] Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (07): : 446 - 454
- [36] Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 687 - 694
- [37] Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) Clinical and Translational Oncology, 2018, 20 : 687 - 694
- [38] New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Dec, 10.1007/s12094-022-03046-9, 2022) CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05): : 1488 - 1488
- [39] Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (05): : 338 - 349
- [40] Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) Clinical and Translational Oncology, 2012, 14 : 338 - 349